Dose-intensified temozolomide plus CAR immunotherapy significantly... | Download Scientific Diagram
Biomedicines | Free Full-Text | Considering the Experimental Use of Temozolomide in Glioblastoma Research
Convection-enhanced delivery of temozolomide and whole cell tumor immunizations in GL261 and KR158 experimental mouse gliomas | BMC Cancer | Full Text
Convection-enhanced delivery of temozolomide and whole cell tumor immunizations in GL261 and KR158 experimental mouse gliomas | BMC Cancer | Full Text
Adaptive Immune Response to and Survival Effect of Temozolomide- and Valproic Acid-induced Autophagy in Glioblastoma | Anticancer Research
Intranasal Delivery of Temozolomide-Conjugated Gold Nanoparticles Functionalized with Anti-EphA3 for Glioblastoma Targeting | Molecular Pharmaceutics
Temozolomide antagonizes oncolytic immunovirotherapy in glioblastoma | Journal for ImmunoTherapy of Cancer
Improved Brain Penetration and Antitumor Efficacy of Temozolomide by Inhibition of ABCB1 and ABCG2 - ScienceDirect
Combined Delivery of Temozolomide and siPLK1 Using Targeted Nanopartic | IJN
Developing a clinically relevant radiosensitizer for temozolomide-resistant gliomas | PLOS ONE
Increased the TMZ concentration in brain by poly(2-ethyl-2-oxazoline) conjugated temozolomide prodrug micelles for glioblastoma treatment - ScienceDirect
![PDF] Preclinical antitumor activity of temozolomide in mice: efficacy against human brain tumor xenografts and synergism with 1,3-bis(2-chloroethyl)-1-nitrosourea. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/b90685392ce0e4c448de2dd652035bc818c0ce1e/3-Table1-1.png "PDF] Preclinical antitumor activity of temozolomide in mice: efficacy against human brain tumor xenografts and synergism with 1,3-bis(2-chloroethyl)-1-nitrosourea. | Semantic Scholar")
PDF] Preclinical antitumor activity of temozolomide in mice: efficacy against human brain tumor xenografts and synergism with 1,3-bis(2-chloroethyl)-1-nitrosourea. | Semantic Scholar
287. Improved Outcomes Following Drug-Resistant Immunotherapy in a Human Xenograft Model of Temozolomide-Resistant Glioblastoma Multiforme: Molecular Therapy
Efficacy of Asparaginase Erwinia chrysanthemi With and Without Temozolomide Against Glioma Cells and Intracranial Mouse Medulloblastoma | Anticancer Research
Combination therapy in a xenograft model of glioblastoma: enhancement of the antitumor activity of temozolomide by an MDM2 antagonist in: Journal of Neurosurgery Volume 126 Issue 2 (2017) Journals
A combined treatment regimen of MGMT-modified γδ T cells and temozolomide chemotherapy is effective against primary high grade gliomas | Scientific Reports
Curcumin sensitizes glioblastoma to temozolomide by simultaneously generating ROS and disrupting AKT/mTOR signaling
Combining Temozolomide and lysate in a curative treatment improves... | Download Scientific Diagram
Temozolomide combined with PD-1 Antibody therapy for mouse orthotopic glioma model - ScienceDirect
Convection-enhanced delivery of temozolomide and whole cell tumor immunizations in GL261 and KR158 experimental mouse gliomas | BMC Cancer | Full Text
Effect of temozolomide (TMZ) treatment (10 and 100 uM) on the size of... | Download Scientific Diagram
Frontiers | Combination of Endothelial-Monocyte-Activating Polypeptide-II with Temozolomide Suppress Malignant Biological Behaviors of Human Glioblastoma Stem Cells via miR-590-3p/MACC1 Inhibiting PI3K/AKT/mTOR Signal Pathway
Combination of temozolomide with immunocytokine F16–IL2 for the treatment of glioblastoma | British Journal of Cancer
Temozolomide antagonizes oncolytic immunovirotherapy in glioblastoma | Journal for ImmunoTherapy of Cancer
Dual functionalized brain-targeting nanoinhibitors restrain temozolomide-resistant glioma via attenuating EGFR and MET signaling pathways | Nature Communications
